Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Monika Rau & Andreas Geier. (2021) An update on drug development for the treatment of nonalcoholic fatty liver disease – from ongoing clinical trials to future therapy. Expert Review of Clinical Pharmacology 14:3, pages 333-340.
Read now
Read now
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher & Amedeo Lonardo. (2018) Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 12:4, pages 351-367.
Read now
Read now
Jason C Simeone, Jay P Bae, Byron J Hoogwerf, Qian Li, Axel Haupt, Ayad K Ali, Marilyn K Boardman & Beth L Nordstrom. (2017) Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes. Clinical Epidemiology 9, pages 679-688.
Read now
Read now
Articles from other publishers (26)
Hao Ren, Dawei Yang, Hui Xu, Xiaofei Tong, Xinyan Zhao, Qianyi Wang, Yameng Sun, Xiaojuan Ou, Jidong Jia, Hong You, Zhenchang Wang & Zhenghan Yang. (2024) The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model. Heliyon 10:2, pages e24558.
Crossref
Crossref
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt & Alastair D. Burt. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
330
401
.
Marcelo Hatto, Victor Kenzo Ivano, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim & Everton Cazzo. (2023) Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery. Obesity Surgery 33:5, pages 1580-1586.
Crossref
Crossref
Ajay Duseja, S.P. Singh, Arka De, Kaushal Madan, Padaki Nagaraja Rao, Akash Shukla, Gourdas Choudhuri, Sanjiv Saigal, Shalimar, Anil Arora, Anil C. Anand, Ashim Das, Ashish Kumar, Chundamannil E. Eapen, Krishnadas Devadas, Kotacherry T. Shenoy, Manas Panigrahi, Manav Wadhawan, Manish Rathi, Manoj Kumar, Narendra S. Choudhary, Neeraj Saraf, Preetam Nath, Sanjib Kar, Seema Alam, Samir Shah, Sandeep Nijhawan, Subrat K. Acharya, Vinayak Aggarwal, Vivek A. Saraswat & Yogesh K. Chawla. (2023) Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Clinical and Experimental Hepatology 13:2, pages 273-302.
Crossref
Crossref
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål & Hannes Hagström. (2022) Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up. Liver International 42:12, pages 2769-2780.
Crossref
Crossref
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis & Michail Pitiakoudis. (2022) Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 29:7, pages 4478-4510.
Crossref
Crossref
Arka De, Amarjit Keisham, Saurabh Mishra, Manu Mehta, Nipun Verma, Madhumita Premkumar, Sunil Taneja, Ashim Das, Virendra Singh & Ajay Duseja. (2022) FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis – Validation in an Indian Cohort. Journal of Clinical and Experimental Hepatology 12:2, pages 440-447.
Crossref
Crossref
Nina Gyorfi, Andras Vereczkei, Zoltan Karadi, Karoly Kalmar Nagy, Zoltan Vizvari, Zoltan Sari, Peter Odry, Adrian Robert Gal & Attila Toth. (2021) The next milestone in clinical trial of a measurement system developed to diagnose NAFLD. The next milestone in clinical trial of a measurement system developed to diagnose NAFLD.
Christoph G Dietrich, Monika Rau & Andreas Geier. (2021) Screening for nonalcoholic fatty liver disease-when, who and how?. World Journal of Gastroenterology 27:35, pages 5803-5821.
Crossref
Crossref
Andreas Geier, Dina Tiniakos, Helmut Denk & Michael Trauner. (2021) From the origin of NASH to the future of metabolic fatty liver disease. Gut 70:8, pages 1570-1579.
Crossref
Crossref
Chang‐Hai Liu, Javier Ampuero, Michael Pavlides, Vincent Wai‐Sun Wong, Jian‐Gao Fan, Lang Bai, Hong Li, Dong‐Bo Wu, Ling‐Yun Zhou, Ling‐Yao Du, Tian‐Kuo Yang, Wei Jiang, Ying Shi, Antonio Gil‐Gómez, Wen‐Ting Zhang, Jia‐Xu Liang, Manuel Romero‐Gómez & Hong Tang. (2021) Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 36:7, pages 1754-1768.
Crossref
Crossref
Judith Aron-Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp & Karine Clément. (2020) Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?. Gastroenterology 158:7, pages 1881-1898.
Crossref
Crossref
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp & Karine Clément. (2020) Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology 17:5, pages 279-297.
Crossref
Crossref
Toshihiro Niikura, Kento Imajo, Anna Ozaki, Takashi Kobayashi, Michihiro Iwaki, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Hiroyuki Kirikoshi, Satoru Saito & Atsushi Nakajima. (2020) Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver. Diagnostics 10:3, pages 129.
Crossref
Crossref
Alessandro FurlanMitchell E. TublinLan YuKapil B. ChopraAnita LippelloJaideep Behari. (2020) Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. American Journal of Roentgenology 214:1, pages W20-W26.
Crossref
Crossref
Rish K. Pai. (2019) NAFLD Histology: a Critical Review and Comparison of Scoring Systems. Current Hepatology Reports 18:4, pages 473-481.
Crossref
Crossref
Katharina Staufer, Emina Halilbasic, Walter Spindelboeck, Magdalena Eilenberg, Gerhard Prager, Vanessa Stadlbauer, Andreas Posch, Petra Munda, Rodrig Marculescu, Barbara Obermayer-Pietsch, Judith Stift, Carolin Lackner, Michael Trauner & Rudolf E Stauber. (2019) Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European Gastroenterology Journal 7:8, pages 1113-1123.
Crossref
Crossref
Benjamin H. Mullish, Naveenta Kumar, Robert D. Goldin & Pinelopi Manousou. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e
395
407
.
Carolin Lackner & Dina Tiniakos. (2019) Fibrosis and alcohol-related liver disease. Journal of Hepatology 70:2, pages 294-304.
Crossref
Crossref
Lisa K. Koch & Matthew M. Yeh. (2018) Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging. Annals of Diagnostic Pathology 37, pages 83-90.
Crossref
Crossref
Lina Jiang, Mei Yang, Xi Li, Yijin Wang, Guangde Zhou & Jingmin Zhao. (2018) CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte–Stellate Cell Crosstalk. The Journal of Clinical Endocrinology & Metabolism 103:11, pages 3974-3985.
Crossref
Crossref
Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller & Manuel Romero-Gómez. (2018) Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica. Gastroenterología y Hepatología 41:5, pages 328-349.
Crossref
Crossref
Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller & Manuel Romero-Gómez. (2018) Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. Gastroenterología y Hepatología (English Edition) 41:5, pages 328-349.
Crossref
Crossref
Detlef Schuppan, Rambabu Surabattula & Xiao Yu Wang. (2018) Determinants of fibrosis progression and regression in NASH. Journal of Hepatology 68:2, pages 238-250.
Crossref
Crossref
Mattias Ekstedt, Patrik Nasr & Stergios Kechagias. (2017) Natural History of NAFLD/NASH. Current Hepatology Reports 16:4, pages 391-397.
Crossref
Crossref
Zobair M. Younossi, Maria Stepanova, Nila Rafiq, Linda Henry, Rohit Loomba, Hala Makhlouf & Zachary Goodman. (2017) Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease. Hepatology Communications 1:5, pages 421-428.
Crossref
Crossref